Yamaoka, Kunihiro
Article History
First Online: 18 May 2016
Compliance with Ethical Standards
:
: No sources of funding were used to assist in the preparation of this article.
: Kunihiro Yamaoka has received consultant fees from Pfizer, Chugai Pharma, Mitsubishi-Tanabe Pharma, and Abbvie; has received honoraria from Pfizer, Chugai Pharma, Mitsubishi-Tanabe Pharma, Bristol-Myers Squibb, Takeda Industrial Pharma, GlaxoSmithkline, Nippon Shinyaku, Eli lilly, Janssen Pharma, Eisai Pharma, Astellas Pharma, and Actelion Pharmaceuticals; and has received research support from Chugai Pharma and Mitsubishi-Tanabe Pharma.
Free to read: This content has been made available to all.